Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v5-EN
Language English English
Date Updated 2020-05-26 2020-05-26
Drug Identification Number 02247022 02247022
Brand name DEFEROXAMINE MESYLATE FOR INJECTION DEFEROXAMINE MESYLATE FOR INJECTION
Common or Proper name Deferoxamine Mesylate for Injection Deferoxamine Mesylate for Injection
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients DEFEROXAMINE MESYLATE DEFEROXAMINE MESYLATE
Strength(s) 2G 2G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAPERITONEAL INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAPERITONEAL INTRAVENOUS SUBCUTANEOUS
Packaging size 2g vial 2g vial
ATC code V03AC V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-03-31 2020-03-31
Estimated end date
Actual end date 2020-05-25 2020-05-25
Shortage status Resolved Resolved
Company comments
Health Canada comments